31 Mar 2023
Assets77.88
Total Income137.40
EBITDA8.91
Profit After Tax3.75
NET Worth19.44
Reserves and Surplus18.19
Total Borrowing24.37
At a glance
Updated 2026-08-24The shares listed at ₹116.00, a 1.75% move from the issue price. Mahamaya Lifesciences is a SME IPO with an issue size of ₹70.44 crore, proposed for listing on BSE SME. The offer opens on 11th Nov 2025 and closes on 13th Nov 2025. The issue structure includes a fresh issue of ₹60.75 crore and an offer-for-sale component of ₹6.16 crore. The current listing schedule points to 18th Nov 2025.
Issue details
Listing atBSE SME
Issue typeBook Build Issue
Issue size₹70.44 Cr
Fresh issue₹60.75 Cr
Offer for sale₹6.16 Cr
Face value₹10
Price band₹108.00–₹114.00
Allotment14th Nov 2025
Listing18th Nov 2025
Listing performance
Full performance ↗Issue price₹114.00
Listing price₹116.00
Current price—
Listing gain1.75%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹0.00
GMP / upper price0.00%
Est. listing₹114.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens11th Nov 2025
Closes13th Nov 2025
Allotment14th Nov 2025
Refund17th Nov 2025
Demat17th Nov 2025
Listing18th Nov 2025
Subscription demand
Full bidding ↗Total1.63×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 2400 | ₹273,600 |
Company
Incorporated2002
Use of proceeds
| Object | Amount |
|---|---|
| Purchase of Equipment for existing Formulation plant | ₹3.75 Cr |
| Funding capital expenditure towards setting up of a new technical manufacturing plant | ₹29.42 Cr |
| Construction of Warehouse Building and Purchase of Machinery | ₹2.53 Cr |
| Funding working capital requirements of the Company | ₹18.00 Cr |
| General Corporate Purposes | ₹8.26 Cr |
| Issue Expenses | ₹2.54 Cr |
| Total | ₹64.50 Cr |
Financials
Full financials ↗31 Mar 2024
Assets112.07
Total Income162.83
EBITDA13.36
Profit After Tax5.22
NET Worth24.66
Reserves and Surplus23.41
Total Borrowing54.63
31 Mar 2025
Assets188.35
Total Income267.17
EBITDA24.64
Profit After Tax12.94
NET Worth49.42
Reserves and Surplus31.66
Total Borrowing58.11
30 Jun 2025
Assets218.87
Total Income84.04
EBITDA8.04
Profit After Tax4.10
NET Worth53.50
Reserves and Surplus35.73
Total Borrowing57.72
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 34.94% |
| ROCE | 23.15% |
| Debt / Equity | 1.08% |
| RoNW | 26.19% |
| PAT Margin | 4.84% |
| EBITDA Margin | 9.22% |
| Price to Book Value | 9.4 |
Valuation & shareholding
Pre-IPO EPS7.29
Post-IPO EPS7.01
Pre-IPO P/E15.65
Post-IPO P/E16.25
Promoter holding pre77.27%
Promoter holding post56.35%
Market cap₹266.82 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Purchase of Equipment for existing Formulation plant | ₹3.75 Cr |
| Funding capital expenditure towards setting up of a new technical manufacturing plant | ₹29.42 Cr |
| Construction of Warehouse Building and Purchase of Machinery | ₹2.53 Cr |
| Funding working capital requirements of the Company | ₹18.00 Cr |
| General Corporate Purposes | ₹8.26 Cr |
| Issue Expenses | ₹2.54 Cr |
| Total | ₹64.50 Cr |
Registrar & lead managers
Registrar
Kfin Technologies Ltd.Lead managers
- Oneview Corporate Advisors Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.